ATE305039T1 - Auf chromosom 1 lokalisiertes gen dessen genprodukt mit der alzheimerschen krankheit assoziiert ist. - Google Patents

Auf chromosom 1 lokalisiertes gen dessen genprodukt mit der alzheimerschen krankheit assoziiert ist.

Info

Publication number
ATE305039T1
ATE305039T1 AT96926062T AT96926062T ATE305039T1 AT E305039 T1 ATE305039 T1 AT E305039T1 AT 96926062 T AT96926062 T AT 96926062T AT 96926062 T AT96926062 T AT 96926062T AT E305039 T1 ATE305039 T1 AT E305039T1
Authority
AT
Austria
Prior art keywords
disease
alzheimer
chromosome
gene localized
genes product
Prior art date
Application number
AT96926062T
Other languages
English (en)
Inventor
Ephrat Levy-Lahad
Rudolph E Tanzi
Gerard D Schellenberg
Wilma Wasco
Thomas D Bird
John Mulligan
David J Galas
Original Assignee
Darwin Molecular Corp
Va Medical Ct
Gen Hospital Corp
Ephrat Levy Lahad
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Darwin Molecular Corp, Va Medical Ct, Gen Hospital Corp, Ephrat Levy Lahad filed Critical Darwin Molecular Corp
Application granted granted Critical
Publication of ATE305039T1 publication Critical patent/ATE305039T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4711—Alzheimer's disease; Amyloid plaque core protein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A01K2267/0306—Animal model for genetic diseases
    • A01K2267/0312—Animal model for Alzheimer's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
AT96926062T 1995-07-07 1996-07-05 Auf chromosom 1 lokalisiertes gen dessen genprodukt mit der alzheimerschen krankheit assoziiert ist. ATE305039T1 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US95695P 1995-07-07 1995-07-07
US167595P 1995-07-28 1995-07-28
US217495P 1995-08-11 1995-08-11
US232895P 1995-08-14 1995-08-14
PCT/US1996/011386 WO1997003192A2 (en) 1995-07-07 1996-07-05 Chromosome 1 gene and gene products related to alzheimer's disease

Publications (1)

Publication Number Publication Date
ATE305039T1 true ATE305039T1 (de) 2005-10-15

Family

ID=27485043

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96926062T ATE305039T1 (de) 1995-07-07 1996-07-05 Auf chromosom 1 lokalisiertes gen dessen genprodukt mit der alzheimerschen krankheit assoziiert ist.

Country Status (7)

Country Link
US (2) US6468791B1 (de)
EP (2) EP1637600A1 (de)
JP (3) JP4073955B2 (de)
AT (1) ATE305039T1 (de)
CA (1) CA2226255A1 (de)
DE (1) DE69635207T2 (de)
WO (1) WO1997003192A2 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6210919B1 (en) 1995-04-28 2001-04-03 Hsc Research And Development Limited Partnership Genetic sequences and proteins related to alzheimer's disease
JP5379119B2 (ja) * 1995-04-28 2013-12-25 エイチエスシー リサーチ アンド ディベロップメント リミテッド アルツハイマー病に関連する遺伝子配列およびタンパク質、ならびにその使用
US5986054A (en) * 1995-04-28 1999-11-16 The Hospital For Sick Children, Hsc Research And Development Limited Partnership Genetic sequences and proteins related to alzheimer's disease
US6531586B1 (en) 1995-04-28 2003-03-11 The Hospital For Sick Children Genetic sequences related to Alzheimer's Disease
WO1997007213A2 (en) * 1995-08-16 1997-02-27 President And Fellows Of Harvard College Assay for identifying genes causing chromosome non-disjunction
WO1997027296A1 (en) * 1996-01-26 1997-07-31 Hsc Research And Development Limited Partnership Nucleic acids and proteins related to alzheimer's disease, and uses therefor
ES2128265B1 (es) * 1997-06-04 2000-03-01 Euroespes S A Kit genetico para la caracterizacion molecular de la enfermedad de alzheimer.
TWI239847B (en) 1997-12-02 2005-09-21 Elan Pharm Inc N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease
US7964192B1 (en) 1997-12-02 2011-06-21 Janssen Alzheimer Immunotherapy Prevention and treatment of amyloidgenic disease
US20080050367A1 (en) 1998-04-07 2008-02-28 Guriq Basi Humanized antibodies that recognize beta amyloid peptide
US7790856B2 (en) 1998-04-07 2010-09-07 Janssen Alzheimer Immunotherapy Humanized antibodies that recognize beta amyloid peptide
AU1957299A (en) 1998-01-09 1999-07-26 Governing Council Of The University Of Toronto, The Presenilin protein interactions
US7700751B2 (en) 2000-12-06 2010-04-20 Janssen Alzheimer Immunotherapy Humanized antibodies that recognize β-amyloid peptide
JP2003018991A (ja) * 2001-06-27 2003-01-21 Japan Science & Technology Corp プレセニリン−２遺伝子エキソン５欠損型スプライシング異常の生成に関与する核酸
MY139983A (en) 2002-03-12 2009-11-30 Janssen Alzheimer Immunotherap Humanized antibodies that recognize beta amyloid peptide
TWI306458B (en) 2003-05-30 2009-02-21 Elan Pharma Int Ltd Humanized antibodies that recognize beta amyloid peptide
AR052051A1 (es) 2004-12-15 2007-02-28 Neuralab Ltd Anticuerpos ab humanizados usados en mejorar la cognicion
US8784810B2 (en) 2006-04-18 2014-07-22 Janssen Alzheimer Immunotherapy Treatment of amyloidogenic diseases
WO2009017467A1 (en) 2007-07-27 2009-02-05 Elan Pharma International Limited Treatment of amyloidogenic diseases
CN101467018B (zh) * 2006-06-12 2011-11-16 卡泊尔投资公司 接管检验设备及方法
US8003097B2 (en) 2007-04-18 2011-08-23 Janssen Alzheimer Immunotherapy Treatment of cerebral amyloid angiopathy
JO3076B1 (ar) 2007-10-17 2017-03-15 Janssen Alzheimer Immunotherap نظم العلاج المناعي المعتمد على حالة apoe
US9067981B1 (en) 2008-10-30 2015-06-30 Janssen Sciences Ireland Uc Hybrid amyloid-beta antibodies
CN104011192B (zh) * 2011-12-20 2017-08-25 荷兰联合利华有限公司 包含去污聚合物的各向同性液体洗涤剂

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6210919B1 (en) * 1995-04-28 2001-04-03 Hsc Research And Development Limited Partnership Genetic sequences and proteins related to alzheimer's disease
US5986054A (en) * 1995-04-28 1999-11-16 The Hospital For Sick Children, Hsc Research And Development Limited Partnership Genetic sequences and proteins related to alzheimer's disease

Also Published As

Publication number Publication date
JP2001517922A (ja) 2001-10-09
JP4073955B2 (ja) 2008-04-09
EP1637600A1 (de) 2006-03-22
US20030180880A1 (en) 2003-09-25
CA2226255A1 (en) 1997-01-30
JP2008035863A (ja) 2008-02-21
DE69635207T2 (de) 2006-06-22
US6468791B1 (en) 2002-10-22
WO1997003192A2 (en) 1997-01-30
EP0846171B1 (de) 2005-09-21
EP0846171A2 (de) 1998-06-10
JP2008035862A (ja) 2008-02-21
DE69635207D1 (de) 2006-02-02
WO1997003192A3 (en) 1997-04-03

Similar Documents

Publication Publication Date Title
ATE305039T1 (de) Auf chromosom 1 lokalisiertes gen dessen genprodukt mit der alzheimerschen krankheit assoziiert ist.
ATE315087T1 (de) Neuartige auf p53 ansprechende gene
Coen et al. Construction of hybrid proteins that migrate retrogradely and transynaptically into the central nervous system
WO1998007850A3 (en) Agents for pre-symptomatic detection and therapeutic targeting of alzheimer's disease and down syndrome in humans
EP1439230A3 (de) Menschliche transmembranprotein TMP-2 gen
CY1107552T1 (el) Ly6h γονιδιο
CY1111950T1 (el) 32 ανθρωπινες εκκρινομενες πρωτεϊνες
WO1999053061A3 (en) Tumor associated nucleic acids and uses therefor
ES2178640T3 (es) Proteina de transferencia de trigliceridos micro9somicos.
DE69736002D1 (de) GEN ASSOZIIERT MIT IgA GLOMERULONEPHRITIS
FR2744455B1 (fr) Nouvelles sequences d'acides nucleiques de la famille des facteurs suppresseurs de tumeurs, produits d'expression correspondants et leurs applications
DE69839765D1 (de) Lage-1 tumor-assozierte nukleinsäuren
ES2170082T3 (es) Transactivador de mhc clase ii (ciita) y sus usos.
WO2000043495A3 (en) 33 human secreted proteins
ATE236977T1 (de) Verwendung einer rekombinanten dna für die herstellung eines medikaments, wobei die rekombinante dna eine dna umfasst, die die sm1- isoform des proteins der schweren kette von myosin der glatten muskulatur codiert
DE69519654T2 (de) htFIIIA Gen
WO2001034769A3 (en) 24 human secreted proteins
MX9801603A (es) Alteraciones geneticas relacionadas con la enfermedad de alzheimer hereditaria.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties